z-logo
open-access-imgOpen Access
Unique Genomic Landscape of High-Grade Neuroendocrine Cervical Carcinoma: Implications for Rethinking Current Treatment Paradigms
Author(s) -
Ramez N. Eskander,
Julia A. Elvin,
Laurie M. Gay,
Jeffrey S. Ross,
Vincent A. Miller,
Razelle Kurzrock
Publication year - 2020
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.19.00248
Subject(s) - pten , cohort , cancer research , cdkn2b , oncology , malignancy , msh2 , medicine , biology , arid1a , amplicon , pi3k/akt/mtor pathway , cancer , cdkn2a , gene , genetics , apoptosis , mutation , colorectal cancer , polymerase chain reaction , dna mismatch repair
High-grade neuroendocrine cervical cancer (HGNECC) is an uncommon malignancy with limited therapeutic options; treatment is patterned after the histologically similar small-cell lung cancer (SCLC). To better understand HGNECC biology, we report its genomic landscape.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom